Skip to main content
IDF logo

NavigateAPDS and Path4Ward overview

February 28, 2024

This flyer provides information on two sponsored, no-charge genetic testing programs available for people who are suspected of having either activated PI3K delta syndrome (APDS), chronic neutropenia, or WHIM syndrome. Find out if your patient qualifies.

  • For eligible patients suspected of having APDS, Pharming offers the navigateAPDS program.
  • For eligible patients suspected of having chronic neutropenia or WHIM syndrome, X4 offers the Path4Ward program. 
Download print material

Requires entering your name and email to download resource and receive IDF emails.

This material is not available to be mailed in hard copy.

Please provide your name and email to view the file.